Short Interest in Ocean Biomedical, Inc. (NASDAQ:OCEAW) Decreases By 35.1%

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a significant decrease in short interest in September. As of September 30th, there was short interest totalling 2,400 shares, a decrease of 35.1% from the September 15th total of 3,700 shares. Based on an average trading volume of 40,400 shares, the days-to-cover ratio is presently 0.1 days.

Ocean Biomedical Price Performance

Shares of Ocean Biomedical stock remained flat at $0.04 during trading hours on Friday. The company’s stock had a trading volume of 22,529 shares, compared to its average volume of 42,346. Ocean Biomedical has a 12 month low of $0.02 and a 12 month high of $0.70. The stock has a 50 day simple moving average of $0.04 and a 200 day simple moving average of $0.07.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.